Aranesp Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis
Conditions:   Anaemia;   Chronic Kidney Disease (CKD)Intervention:   Sponsor:   AmgenActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2014 Category: Research Source Type: clinical trials

Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis
Conditions:   Anaemia;   Chronic Kidney Disease (CKD)Intervention:   Sponsor:   AmgenActive, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2014 Category: Research Source Type: clinical trials

Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis
Conditions:   Anaemia;   Chronic Kidney Disease (CKD)Intervention:   Sponsor:   AmgenRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2014 Category: Research Source Type: clinical trials

Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis
Conditions:   Anaemia;   Chronic Kidney Disease (CKD)Intervention:   Sponsor:   AmgenActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2014 Category: Research Source Type: clinical trials

Darbepoetin Alfa MDS Companion Protocol
Condition:   Myelodysplastic Syndrome (MDS)Intervention:   Drug: Darbepoetin AlfaSponsor:   AmgenRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 25, 2014 Category: Research Source Type: clinical trials

Darbepoetin Alfa MDS Companion Protocol
Condition:   Myelodysplastic Syndrome (MDS)Intervention:   Drug: Darbepoetin AlfaSponsor:   AmgenRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 24, 2014 Category: Research Source Type: clinical trials

FG-4592 in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa
Condition:   Anemia in Chronic Kidney Disease in Non-dialysis PatientsInterventions:   Drug: FG-4592;   Drug: darbepoetin alfaSponsors:   Astellas Pharma Europe B.V.;   FibroGenRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2013 Category: Research Source Type: clinical trials